J&J Pauses Enrollment In Trial Of AC Immune-Partnered Anti-Tau Immunotherapy

Study Is Ongoing During Review

 
• By Mandy Jackson
  
Recruitment is paused, but dosing continues in already enrolled patients (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D